2011 Fiscal Year Final Research Report
Characterization of signaling pathways that are regulated through cell surface molecular interaction in B cell lymphoma.
Project/Area Number |
22790071
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Single-year Grants |
Research Field |
Biological pharmacy
|
Research Institution | Kochi University |
Principal Investigator |
KOTANI Norihiro 高知大学, 教育研究部・医療学系, 助教 (90342782)
|
Research Collaborator |
HONKE Koichi 高知大学, 教育研究部・医療学系, 教授 (80190263)
|
Project Period (FY) |
2010 – 2011
|
Keywords | 膜タンパク質 / 分子間相互作用 / Bリンパ腫細胞 |
Research Abstract |
Many plasma membrane-resident proteins collaborate with other molecules by molecular interactions in a variety of biological events. Herein, we have studied interacted molecules associated with CD20-rituximab complex on B cell lymphoma cells. We found some cell surface molecules, such as FGFR3, HLA class II, and HSP-90 are interacted with CD20-rituximab complex. Above all, FGFR3 possibly plays important role for efficacy of rituximab-dependent cytotoxic effect through cell cycle signaling pathways.
|
Research Products
(16 results)